PMC:7425568 / 1787-1962
Annnotations
LitCovid-PD-FMA-UBERON
| Id | Subject | Object | Predicate | Lexical cue | fma_id |
|---|---|---|---|---|---|
| T3 | 102-106 | Body_part | denotes | head | http://purl.org/sig/ont/fma/fma7154 |
LitCovid-PD-UBERON
| Id | Subject | Object | Predicate | Lexical cue | uberon_id |
|---|---|---|---|---|---|
| T3 | 102-106 | Body_part | denotes | head | http://purl.obolibrary.org/obo/UBERON_0000033 |
LitCovid-PD-CLO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T11 | 102-106 | http://purl.obolibrary.org/obo/UBERON_0000033 | denotes | head |
| T12 | 102-106 | http://www.ebi.ac.uk/efo/EFO_0000964 | denotes | head |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T14 | 0-175 | Sentence | denotes | The first reports of possible mutations and decreases in potency came from Dr. Alberto Zangrillo, the head of intensive care at the San Raffaele hospital in Milan in Lombardy. |